菊福堂生物控股有限公司（08217）于2026年5月5日发布截至2026年4月30日的股份变动月报表。公告显示，公司法定股本及已发行股份数量整体保持不变。
公司法定股本为5亿股普通股，每股面值0.16港元，总额8,000万港元；本月末与上月相比无新增或减少。已发行股份（不含库存股）总数仍为301,860,000股，库存股数量为0股，均与上月持平。本期内未发生任何新增发行、购回或注销股份行为。
股权激励方面，公司仍维持此前已授出但尚未行使的股份期权总数：第一项股票期权为10,698,480股，行使价每股0.315港元；第二项股票期权为9,144,000股，行使价每股0.163港元，上述期权数量在报告期内无变动。
根据公告，菊福堂生物控股有限公司确认已遵守香港联合交易所有限公司上市规则及其他适用法律法规。公告由公司秘书谭美珠签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.